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Summary 
A flow cytometric phenotype for isolated adult central nervous system (CNS) ramified microglia 
was previously defined (CD45 l~  CDllb/c +) in the Lewis strain rat,  that clearly distinguished 
these cells  from all blood-derived leucocytes, the latter being CD45r~g  h.  Consistent  with  the 
reported lack of major histocompatibility complex (MHC) expression in the CNS, isolated microglia 
were  mostly  MHC  class  II-.  Employing  these  phenotypic  criteria,  we  now  show  that  a 
proportion of microglia in Brown Norway (BN) strain rats are constitutively MHC class II + . 
In spinal cord, up to 25% of microglia are distinctly positive and most have some level of expression. 
In situ staining  of MHC class  II + microglial  ceils in BN rats indicates  that  positive cells  are 
typical of ramified microglia on the grounds of both morphological appearance and anatomical 
location.  In Lewis (LEW) rats,  the few MHC class II-expressing cells isolated from the normal 
CNS are CD45his a blood-derived cells and not resident microglia.  After infection of both LEW 
and BN rats with a neurotropic murine hepatitis virus (MHV-JHM), MHC class II was rapidly 
upregulated  on microglia in the BN but not in the LEW strain.  In the latter,  inflammatory 
cells were the predominant  MHC class II-expressing population.  Nevertheless, most microglia 
in the LEW strain could, after some delay,  be induced to express MHC class II after transfer 
of an experimental autoimmune encephalomyelitis (EAE)-inducing encephalitogenic T cell line. 
Paradoxically,  strains resistant to EAE (exemplified by the BN) contained more constitutive MHC 
class  II-expressing  microglia  than  susceptible ones,  when a variety of strains were examined. 
The results clearly establish that  the normal  CNS may contain MHC class II-expressing cells 
that  are  a resident rather  than  a transient  blood-derived population.  It is  significant  that  this 
expression is strain related, but there is no evidence that microglial cell constitutive MHC class 
II expression predisposes to EAE  susceptibility. 
U 
ntil relatively recently, the prevailing view of the cen- 
tral  nervous  system  (CNS) 1 from  an  immunological 
perspective, was dominated by the apparent  deficiencies  of 
this tissue, which include the lack of real lymphatic drainage, 
the exclusion of most lymphoid cells because of the presence 
of the blood-brain barrier,  and the lack of MHC expression 
on most CNS parenchymal cells (for reviews see references 
1 and 2).  However, a number of lines of experimental  (3) 
1 Abbreviations used in this paper: BN, Brown Norway; CNS, central 
nervous system; EAE, experimental autoimmune encephalomyelitis; F1, 
(LEW x BN)Ft; LEW, Lewis; MBP, myelin basic  protein; MHV, murine 
hepatitis virus. 
and circumstantial evidence (2) now indicate that despite these 
conditions, the CNS is effectively patrolled by the immune 
system. Exactly how this is achieved given the conditions under 
which the immune system must operate is not absolutely dear. 
Nevertheless, the demonstration of MHC class II induction 
on glial cells by T cell factors such as IFN-3~ (4), the presence 
in the CNS of macrophage-like perivascular cells with in vivo 
APC ability (5), and the observation that  activated T  cells 
may nonspecifically cross the blood-brain barrier  (1, 6), al- 
leviate  to  some  extent  the  mystique  surrounding  likely 
processes of immune system intervention within the CNS. 
There  are  still  many  facets of immune-central  nervous 
system interactions  that  require clarification.  In particular, 
it is still not known exactly what role glial cells such as as- 
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mune responses. Astrocytes are effective APC in vitro, at least 
for secondary CD4 + T cell responses (1, 7) whereas after the 
development of inflammation in the human and animal CNS, 
microglia (together with inflammatory monocytes) are the 
most abundant MHC class II-expressing population (8, 9). 
MHC expression  on either cell type after inflammation is 
always taken to indicate that T cell-glial cell interactions can 
then proceed, leading to further T  cell activation. There is 
no evidence to suggest that this actually occurs in vivo, de- 
spite the substantial body of in vitro data including our own 
studies with astrocytes  (7) supporting the role of glial cells 
as effective APC for proliferative  T  cell responses.  Indeed, 
a recent study indicates that the environment of the CNS 
is not particularly conducive to T  cell activation (10). 
Employing new methodology for the isolation and char- 
acterization of ramified (resident)  microglia from the adult 
rat CNS (11), we now report that in some strains of rats, 
the Brown Norway (BN) in particular, a high proportion 
of microglia are  constitutively MHC  class II +.  The BN 
strain is one of the most resistant to the induction of the 
CD4 + T  cell-mediated disease, experimental autoimmune 
encephalomyelitis (EAE). In highly EAE-susceptible strains 
such as the Lewis (LEW), few microglia express MHC class 
II, and in this case, nonresident blood-derived cells are the 
predominant MHC class II-expressing population isolated 
from the normal CNS. The result stress the point that resi- 
dent ceils of the CNS can express MHC class II under normal, 
noninflammatory  conditions, but that this expression is very 
strain dependent. It is significant that mere expression of  MHC 
class II on microglia is not indicative of heightened suscepti- 
bility to inflammatory T  cell responses  in the CNS. 
Materials and Methods 
Animals and Irradiation Chimeras.  8-10-wk-old female  rats were 
obtained from Zentralinstitut far Versuchstierzucht  (Hannover, Ger- 
many); Moellegard  Ltd. (Skensved,  Denmark); Olac Ltd. (Bicester, 
UK); or were bred in our own facilities (Blackburn, University 
of Sydney).  Strains used were Lewis (LEW, RTlt), Brown Norway 
(BN, RTln), (LEW  x  BN)FI (F  0, PVG (R.Tlc), F344 (RTI~"t), 
and Wistar Furth (RTI~). Athymic PVG (RT1  c, rnu/rnu) were 
from Olac Ltd. (LEW  x  BN)F1 -~ LEW and (LEW  x  BN)F1 
BN irradiation bone marrow chimeras were prepared and as- 
sessed as described (11). 
Induction of CNS Inflammation.  Viral  encephalomyelitis  was in- 
duced by intracerebral injection of rats with the neurotropic JHM 
strain of routine hepatitis virus (MHV-JHM), as described (11). 
EAE was induced by subcutaneous injection of rats with myelin 
basic protein (MBP)/CFA (12) or by transfer of the CD4 + MBP- 
specific encephalitogenic  T cell line, 266/87, to naive  LEW rats (13). 
Isolation of  Microglia and CNS.associated Leucocytes.  The general 
procedures for vascular perfusion, collagenase/DNase digestion of 
CNS material, and Percoll gradient separation of CNS cells are 
detailed elsewhere (11), but note should be made of some changes 
and corrections to  this  original method:  (a)  103  U  of DNase 
should be used per rat CNS, not 104 U; and (b) other types of 
collagenase may be employed in addition to Serva type II (used at 
"~ 10 U/CNS).  Sigma Immunochemicals (St. Louis, MO) type I 
(260 U/rag) gives high recoveries when used at up to 15 U/CNS. 
Monoclonal and Polyclonal  Antibodies.  Biotinylated  rat mAb that 
distinguish between MHC class I of LEW and BN rats (mAb 
K2/15S, RT1.A t+  and RTI.A"-;  mAb  YR5/12,  RT1.A "+  and 
RT1.A t-) were those used in a previous study (11). Mouse mAb 
specific for rat cell surface antigens were MRC OX1  (anti-rat 
CD45), MRC OX6 (anti-rat monomorphic MHC class II, RTI.B 
[I-A]), MRC OX18 (anti-rat monomorphic MHC class I, RTI.A), 
MRC OX26  (anti-rat  transferrin receptor), and MRC OX42 
(anti-rat CDllb/c). (See 11, 14, 15 for cross-reference  details). Con- 
trol mouse IgG1 mAb were MRC OX21 (anti-human C3bi; [16]), 
L180/1 (anti-sheep LFA-3; [17], provided by Thomas Htinig, In- 
stitiite far Virologic und Immunbiologie, Wfirzburg, FRG), and 
K-1-21 (anti-human free K  light chains, noncrossreactive  on rat Ig). 
Rat Ig-absorbed FITC-conjugated donkey anti-mouse Ig and PE- 
streptavidin were from The Jackson Laboratory (Bar Harbor, ME). 
FITC-conjugated goat  (Fab) anti-mouse  Ig was  from Cappell 
Laboratories (Cochranville,  PA) and rabbit anti-mouse Ig coupled 
to peroxidase or alkaline phosphatase were from Dako (Glostrup, 
Denmark). 
Cell Labeling and Flow Cytometry.  Double labeling of cells for 
flow cytometry (FACScan|  Becton Dickinson & Co., Mountain 
View, CA), with biotinylated rat mAb and mouse mAb tissue cul- 
ture supernatants, was performed as detailed (11). Double labeling 
of cells with two mouse mAb involved the sequential addition of 
the first mAb as tissue culture supernatant, FITC-conjugated goat 
(Fab) anti-mouse Ig in the presence of 20% normal rat serum, 
biotinylated second mAb in the presence of 20% normal mouse 
serum and streptavidin-PE. 
Immunohistology.  Rats were injected intravenously with 2 ml 
MRC OX26 ascites (anti-rat transferrin receptor) plus 5 mg MRC 
OX18 IgG (anti-rat MHC class I) and 30 rain later, the vascular 
bed perfused  with 250 ml PBS. Spinal  cord and brain were removed, 
snap frozen, and 6-#m cryostat sections cut and fixed in 100% ace- 
tone. Anti-transferrin receptor (14) and MHC class I mAb binding 
to brain endothelial cells was revealed by addition of peroxidase- 
conjugated anti-mouse IgG followed  by diaminobenzidine (DAB) 
substrate (brown product). MKC OX6 (anti-MHC class II), MRC 
OX42 (anti-CDllb/c),  or control mAb were then added to the 
sections. The heavy  deposition  of  DAB substrate virtually prevented 
binding  of  these mouse  mAb  by  the  peroxidase-conjugated 
anti-mouse IgG already  on the sections. MHC class II or CDllb/c 
staining was revealed  by addition of alkaline  phosphatase-conjugated 
anti-mouse IgG and the (blue product) substrate 5-bromo-4-chloro- 
3-indolyl  phosphate/nitro  blue tetrazolium  (ratio of 1:1.5  by weight). 
Results 
Irradiation Chimeras Establish Microglial Phenotype in BN and 
LEW  Rats.  Ramified microglia  are  irradiation resistant 
and do  not  swap  to  the  donor  phenotype in  irradiation 
bone marrow chimeras (18). In a previous study, we utilized 
(LEW x  BN)F1 ~  LEW irradiation bone marrow chimeras 
(11) to establish  a definitive phenotype for freshly isolated 
microglia in LEW rats. The most important phenotypic fea- 
ture of these cells was their distinctly low expression  of the 
CD45  molecule as  compared  to  blood-derived leucocytes 
which were CD45hig  h. "Perivascular  cells" a distinct popu- 
lation to microglia, are situated around vessels outside the 
parenchymal basement membrane (19). They are not only 
irradiation sensitive  (20),  but are strongly CD45 + by im- 
munohistochemical staining, unlike microglia, so they can 
probably be classified as CD45 hish. Microglia are also stained 
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determinant  on both  the  rat  CDllb  (Mac-l)  and  CD11c 
(p150/95) molecules (21, 22). However, monocytes, granu- 
locytes, and perivascular cells  (20) are also positive for this 
mAb, so it is not a particularly discriminating marker.  The 
results in Fig. I demonstrate that microglia isolated from BN 
rats have a similar phenotype to those found in the LEW 
strain.  In these experiments, we have utilized the ability of 
a neurotropic murine hepatitis virus (MHV-JHM) to elicit 
a CNS inflammation  in both LEW and BN rats.  This re- 
sponse is generally of a lower magnitude in the latter strain. 
Inflammatory cells of donor phenotype can be distinguished 
easily from irradiation-resistant  host ceils in these chimeras 
by virtue of the former expressing LEW MHC class I in the 
case of Ft ='* BN chimeras (Fig.  1, d-j) or BN MHC class 
I  in  the  case  of F~  --)  LEW  chimeras  (Fig.  1, j-/).  It  is 
notable that the cells (microglia) that are negative for these 
MHC class I markers (that is of host and not donor type), 
are virtually all  CD49 ~  (Fig.  1,  e and  k) and CDllb/c + 
(Fig.  1, f  and/).  Microglia in both rat strains express some 
MHC class I even after isolation from the noninflamed CNS 
(11 and data not shown),  and this is greatly increased after 
viral infection. In BN rats in particular, MHC class I expres- 
sion of the CD45 ~~  population  (microglia,  Fig.  1 b) is at 
least as high  as the inflammatory  cells. 
If progenitor cells within the bone marrow inoculum en- 
tered the adult CNS and differentiated into ramified microglia, 
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Figure  1.  Microglial cell phenotype in BN and LEW rats.  (LEW  x 
BN)Ft --~ LEW and (LEW  x  BN)F1 =-)- BN irradiation bone marrow 
chimeras were prepared at 4 wk of age and injected intracerebrally with 
the neurotropic virus, MHV-JHM 5 wk later.  10 wk after infection, cells 
were isolated from the CNS and double stained for flow cytometric anal- 
)'sis. The control mAb is MRC OX21 (mouse IgG1). The indicated popu- 
lation (e) are of donor cell type (LEW dass I + in the BN host) but are 
CD45 l~  (see  text for details). 
one might expect these cells to express low levels of the CD45 
molecule. However, in noninfected Ft "* parent chimeras up 
to  1 yr of age, we have no evidence to date that  ramified 
microglia  can  develop from blood leucocytes.  That  is,  all 
CD45  l~  cells remain of host phenotype only and do not ex- 
press MHC class I of donor type. In addition, relatively soon 
after viral infection (7-14 d) in both LEW and BN rats, no 
such transition has been observed (11). In Fig.  1, where the 
CNS was obtained 10 wk after infection, there is now some 
evidence that this process may occur, but only significantly in 
BN rats.  The indicated population in Fig.  1 e is atypical in 
being of donor type but CD49  ~  Triple  staining is required 
to ascertain whether  this population  is also CDllb/c +. 
Constitutive  MHC Class II Expression  on BN Microglia.  In 
Ft --* LEW chimeras,  little evidence was found for consti- 
tutive MHC class II expression on microglia in the normal 
CNS (Fig.  2 a, bottom right).  Most MHC class II + cells re- 
covered from the perfused CNS, were of donor phenotype 
(Fig. 2 a, to  F right).  At the peak of the inflammatory episode 
7 d after viral infection, most MHC class II-expressing cells 
recovered from the CNS, were of donor type and therefore, 
inflammatory cells derived from the blood (Fig. 2 b, top right). 
MHC class II expression by LEW microglia was not increased 
at later time points (data not shown). On analysis of normal 
F1 -') BN chimeras,  a very different situation was observed 
where up to  15%  of BN microglial cells were MHC class 
II + (Fig. 2 c, bottom right, LEW MHC class I-). After viral 
infection,  a distinct  MHC class  II + microglial  population 
emerged (Fig.  2 d,  bottom  right).  Levels of expression were 
less than that on inflammatory cells (Fig.  2 d, top right),  al- 
though  there were relatively few of the latter. 
To simplify the analysis  of microglia in other strains and 
to establish that MHC class II expression on BN rat microglia 
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Figure  2.  Constitutive  and  inducible  MHC  class  II  expression  on 
microglia in chimeric BN rats.  Chimeras were prepared as described in 
Fig. 1. Cells were isolated from the CNS of rats infected 7 d previously 
with MHV-JHM or from noninfected controls and double stained for flow 
cytometric analysis.  Shown here are only those stainings which allow dis- 
crimination between donor and host cells. That is, BN MHC class I in 
F1 -') LEW and LEW MHC class  I in F1 "=) BN. 
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Figure  3.  Constitutive  MHC  class  I1  expression on  CD45 l~ 
(microglial) cells in nonchimeric BN rats. CNS cells were isolated from 
normal LEW and BN rats and double stained  for flow cytometric  analysis. 
was not an artefact of the chimeras, cells isolated from the 
CNS of normal rats were analyzed for CD45 and MHC class 
II expression by 2-color flow cytometry. Fig. 3, a and d illus- 
trate CD45 histograms and show typical three-peak profiles 
of  CD45-,  CD45 l~  (microglia),  and  CD45hig  h  (blood- 
derived leucocytes). The results for MHC class II expression 
are  entirely  consistent  with  those  in  the  chimeras  (Fig. 
2). MHC class II expression in LEW rats (Fig. 3 b) is virtu- 
ally  confined  to  the  CD45his  h population,  whereas  many 
CD45 z~  cells in BN rats  (Fig.  3  e) are class  II + .  In many 
cases using this staining protocol where MHC class II is de- 
tected with highly sensitive PE rather than  FITC (Fig.  2), 
the entire BN CD45 z~  population shifts in the direction of 
MHC class II +.  Consistent with the fact that the CD45 l~ 
population are microglia, virtually all of them are CDllb/c + 
(Fig. 3, c and./), whereas only around a half of the CD45his  h 
cells are CD11b/c § . These latter cells are either monocytes 
or granulocytes, whereas the CD45hig  h CDllb/c-  cells (Fig. 
3,  c and f,  bottom  right panels)  are almost  exclusively ot/fl + 
T  cells  (data  not  shown). 
The  existence  of MHC  class  II +  cells  in  the  CNS  of 
normal BN rats  was established finally, by staining of cells 
in  situ  (Fig.  4).  Vessels  were highlighted  by staining  with 
mAb recognizing the transferrin receptor and MHC class I 
Figure 4.  Constitutive MHC class II expression  on BN microglia revealed  in situ. Horizontal cryostat sections of thoracic spinal cord from normal 
LEW (a and c) and BN (b and d) rats. Brown staining in all cases reveals vessels. Blue staining shows cells positive for: (a) MILC OX21 (negative 
control); (b) CDllb/c; (c and d) MHC class II. In each case, the vessels are in focus. Some of the microglia are out of plane,  x 130. 
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substrate.  Addition of a control mAb to LEW spinal cord 
(Fig. 4 a) shows no staining other than the vessels. Numerous 
CDllb/c + cells (microglia) can be seen in BN tissue (Fig. 
4  b).  These pictures are the same for both LEW and BN 
rats. There are no MHC class II + cells seen in LEW spinal 
cord (c), whereas many positive cells are evident in tissue from 
BN rats (Fig. 4 d). Sections at low magnification are shown 
to illustrate the fact that positive cells are not infrequent in 
BN tissue. Most of the positive cells do not lie around vessels, 
and so are not perivascular cells (5,  23).  Microglial MHC 
class II expression is not uniform throughout the normal CNS. 
It tends to be patchy, the highest levels are found in the lumbar 
cord, and this reduces as the cord is ascended. Lowest levels 
are found in the cerebral lobes. In the BN rat, if spinal cord 
only is used  as  a  source  of tissue,  up  to  25%  of isolated 
microglia are truly MHC class II + and most have some ex- 
pression,  albeit weak. 
EAE Susceptibility and MHC Class II Expression.  Having 
established microglial phenotype without having to resort 
to chimeras for analysis, a variety of rat strains were tested 
both for microglial MHC class  II expression and suscepti- 
bility to EAE as induced by standard procedures of MBP/CFA 
injection (Table  1). The clearest point to emerge from this 
study was that high constitutive MHC class  II expression 
on microglia (in normal rats) is not associated with increased 
susceptibility to EAE. BN rat microglia (obtained from two 
sources) expressed the most MHC class II. Wistar Furth and 
PVG rats, both strains resistant or relatively resistant to EAE, 
were variable although clearly lower than the BN. LEW and 
(LEW  x  BN)Ft  rats  are  susceptible  to  EAE but  consis- 
tently both were low expressors,  F344  rats were included 
in the study as it is a strain which, under some circumstances 
(24), is susceptible to EAE. With the immunization protocol 
used here,  minimal disease was observed,  although MHC 
class II expression  on microglia was  similar  to LEW and 
(LEW  x  BN)F1 rats. Why there is some variability in levels 
of expression, particularly in the PVG and Wistar Furth strains 
is unclear, given the inbred nature of these animals. Environ- 
mental factors may be involved but, where we have had the 
opportunity to compare SPF and conventional rats, the trends 
in levels of expression remain the same  -  BN high, LEW 
low,  and so on. 
After viral infection of LEW rats, most of the MHC class 
II-expressing  cells  are  inflammatory rather  than  resident 
microglia (11 and Fig. 2 b), so it is possible that microglial 
cells from this strain are relatively resistant to MHC class 
II enhancement, unlike BN rat microglia. However, in the 
face of a  massive CD4 +  T  cell inflammatory response  as 
occurs in EAE, most microglia do express MHC class II (Fig. 
5).  3 d  after the transfer of an EAE-inducing T  cell line, a 
proportion of blood-derived cells (CD45hig h) are MHC class 
II + as seen in the normal CNS. Compared with control rats 
(not shown), slightly more CD45 high cells are detectable, in- 
dicating an early influx of inflammatory cells and/or the ap- 
pearance of the injected T  cell line in the CNS. There is no 
evidence at  this  stage of MHC  class  II expression by the 
Table  1.  Strain Dependence of Microglial Cell Constitutive MHC 
Class II Expression 
Rat strain 
EAE susceptibility 
Percent  MHC 
class II ~  Clinical 
microglia*  disease  Severity II 
Lewis  5.0  8/8  5 
BN (A)  17.6'  0/8  - 
BN  (B)  11.9'  ND  ND 
(Lewis  x  BN)FI  5.2  2/4  3.5 
F344  5.3  1/3  0.5 
PVG  5.6S  1/4  1 
Wistar Furth  6.8s  0/4  - 
Microglia were isolated from the brain and spinal cord of groups of two 
or three noninfected,  nonimmunized  rats and double stained for FACS  ~ 
analysis. Other groups of rats were injected with MBP/CFA to elicit 
EAE. BN rats were from Germany (A) or the UK (B). Data are from 
three experiments using groups of two Lewis and two BN (A) rats as 
internal controls for each experiment. 
* Average scores are shown. Cells were stained for CD45 (MRC OX1 
supernatant) and MHC class II (biotinylated  MRC OX6; IgG1) or con- 
trol mAb (biotinylated  mouse IgG1 anti-sheep LFA-3). Figures are the 
percentage of CD45  low cells (microglia) staining greater than the nega- 
tive control marker (as illustrated in Fig. 3). The small percentage of 
cells staining positive with the biotinylated control mAb (i.e., greater 
than the set marker) have been subtracted. 
* The entire CD45  l~  population shifted towards MHC class II posi- 
tivity. 
S Average of three rats. Range, 4-8.3%  (PVG) and 4.5-10.6%  (WF). 
Most cells were negative (like LEW) but in some rats, a distinct popula- 
tion was positive. 
Ir Animals that were clinically  ill. 
majority CD45 l~  microglial population. By day 4, there is 
a further increase in the number of CD45hig h cells recovered. 
Most microglia are still MHC class II-. A caveat to the ob- 
servations to day 4  is that our analysis of the whole CNS 
rather than the lower segments of spinal cord where the first 
infiltration is generally observed in EAE, may mean that local- 
ized induction of MHC class II on microglia is missed, be- 
cause of a simple dilution effect. Early induction of MHC 
class II on cells in the vicinity of infiltrating T  lymphocytes 
in LEW rats has been reported, although it i s unclear whether 
the MHC class II + cells were resident microglia or inflam- 
matory cells (8). By day 5, there is a massive inflammatory 
response and dear movement of the CD45 l~  cells to MHC 
class II expression. At day 6, most CD45 l~  cells are MHC 
class II +. It should be noted that once there is a large influx 
of inflammatory cells, the analysis of CD45 l~  ceUs is more 
difficult in nonchimeric rats as, relative to the infiltrating ceils, 
the numbers of microglia isolated are very low. Moreover, 
the demarcation between microglia and infiltrating cells be- 
comes less distinct as the former upregulate their CD45 ex- 
pression  levels,  presumably  as  a  result  of  inflammatory 
cytokines (Fig. 5). However, the irradiation chimera studies 
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Figure  5.  Upregulation of LEW microglial cell MHC class II expres- 
sion after induction of EAE. LEW rats were injected intravenously with 
1.5  x  106 MBP-specific 266/87 line T cells, CNS cells isolated 3-6 d later, 
and the recovered cells double stained for flow cytometry. Analysis quad- 
rants (a, c, e, g) are based on control stainings using the mAbs MRC OX21 
(FITC) and biotinylated I(-1-21 (PE). Gain settings for FI-1 and F1-2 were 
not changed across the time course. MHC class II expression of microglia 
(CD45 l~  cells is illustrated (b, d,f,  and h; filled histograms). These histo- 
grams were generated by examining only those cells  within an analysis 
gate placed around the CD45 l~  population as illustrated in a. The posi- 
tion of this gate was changed for each day as the CD45 expression levels 
increased. (Unfilled line) Control mAb staining (CD45  and biotinylated 
K-1-21  with  analysis  only of CD45 l~  cells)  for each day. 
(11 and Fig. 1) indicate that microglial CD45 expression rarely 
reaches that of PBL or inflammatory cells, so the use of CD45 
levels to distinguish between microglia and inflammatory ceils 
is still valid. Consistent with this is the fact that the majority 
of CD45 t~  cells in Fig. 5 (days 3-6) are CDllb/c + (data not 
shown). Disease severity in the Fig. 5 rats was: day 3, none; 
day 4, loss of tone in tail only; day 5, hind limb weakness; 
and day 6,  bilateral hind limb paralysis. 
Discussion 
These studies demonstrate three points.  First, cells con- 
stitutively expressing MHC class II molecules are present in 
the normal CNS. These MHC class II § cells are not neces- 
sarily a transient population derived from the blood, but can 
be resident (ramified) microglial cells that are an integral part 
of the structure of normal CNS tissue. Second, levels of con- 
stitutive expression vary between strains,  and some strains, 
the BN  in particular,  have considerable numbers of their 
microglia expressing MHC class II antigens. In other strains, 
such as the Lewis,  the main MHC class II-expressing cells 
isolated from the normal CNS are a transient population de- 
rived from the blood, whereas microglial MHC class II ex- 
pression is minimal. Third,  susceptibility to CNS autoim- 
munity (EAE) is, if anything, inversely related to constitutive 
MHC dass II expression. Certainly, the most EAE-susceptible 
strains do not constitutively express MHC class II on their 
microglia. It is probably reasonable in the light of this data 
to bury the concept that heightened susceptibility to CNS 
inflammation and constitutive MHC class II expression, at 
least  on microglia within  the CNS,  are linked.  In  EAE- 
susceptible strains like LEW, MHC class II can be induced 
on microglia (Fig. 5), but it can also be further upregulated 
in the BN  strain given the appropriate stimulus (Fig.  2). 
The irradiation chimera experiments provide strong evi- 
dence that the MHC class II-expressing population in BN 
rats isolated in these studies, are a resident, irradiation-resistant 
population. The early conclusions by Ting et al. (25) using 
irradiation bone marrow chimeras, that brain Ia antigens have 
a bone marrow origin are, therefore, probably only correct 
when the normal constitutive levels in the host strain are very 
low. In F1 ~  LEW rats for example, most of the MHC class 
II expression in the normal CNS, are derived from the donor 
cells and not the host (Fig. 2 a). CNS perivascular cells which 
are irradiation sensitive  (5,  20)  and may constitutively ex- 
press MHC dass II molecules (23),  are one of the popula- 
tions likely to be responsible for donor cell MHC class II 
expression in chimeras. The staining of MHC class II + cells 
in situ in BN rats confirms the predominantly parenchymal 
as opposed to perivascular location of the positive cells. True 
perivascular cells lie outside the parenchymal basement mem- 
brane in the perivascular space (19). Most of the positive cells 
in Fig. 4 are not of this type. Some of the MHC class II + 
cells were relatively close to vessels, but this is consistent with 
the recent observation that microglial processes can, like as- 
trocyte endfeet, form part of the glia limitans (26). 
Is constitutive MHC class II expression T cell dependent ? 
It is now clear that activated T cells traffic through the normal 
CNS (6) and it is possible that these cells could be respon- 
sible for the constitutive MHC class II expression described 
here. Preliminary studies suggest however, that most of it 
is not dependent on T lymphocytes. First, at least 5-6% of 
microglia are MHC class II + in athymic PVG rats. Athymic 
BN rats are not available. Second, in BN rats infected with 
MHV-JHM we have found recently that increased MHC class 
II expression on microglia such as that illustrated in Fig. 
2 d, can be prevented completely by irradiation of the rats 
with 600 R y, which temporarily depletes most T cells. Ap- 
plying this same procedure to normal (noninfected) BN rats, 
MHC class II-expressing microglia are mostly retained, al- 
though there is some loss of the highest expressing popula- 
tion (Schwender, S., and R. D6rries, unpublished observations). 
Does constitutive MHC class II expression on microglia 
have any functional relevance for development of T  cell re- 
sponses in the CNS? It has been known for some time that 
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CNS, microglia (together with inflammatory monocytes) are 
the most abundant MHC class II-expressing population (8, 
9). On the basis of these observations, microglia are increas- 
ingly being viewed as the most likely candidates to fulfill the 
role of APC in the CNS.  APC in this context is taken to 
mean a cell that  will present antigen to T  cells (unprimed 
or primed),  as does a leucocyte dendritic cell for example, 
leading to further T  cell activation and proliferation.  There 
is evidence that microglia purified from the neonatal mouse 
CNS can act as APC for T  cell lines (27). Perivascular cells 
which are distinct from microglia have a demonstrable APC 
function in vivo (5), but it is not known whether fully differen- 
tiated, ramified microglia from adult animals like those iso- 
lated in the present studies, are similarly effective in this re- 
gard.  In essence,  therefore, the appearance of MHC class II 
on microglia after the influx of inflammatory cells is not proof 
that these cells are effective APC in situ. Rather, it only means 
that they have responded to the presence of infiltrating T cells. 
The description here of constitutive MHC class II expres- 
sion on microglia from (some) rat strains resistant to EAE 
and the low levels of expression on susceptible strains,  has 
led us to consider whether microglial MHC expression im- 
parts on these cells,  the ability to interact with and down- 
regulate T  cell responses rather than amplify them.  In sup- 
port  of  this  general  concept  is  the  demonstration  that 
administration  of IFN-3'  intraventricularly just before the 
normal time of EAE onset (resulting in high MHC class II 
expression on CNS glial cells), effectively inhibits clinical dis- 
ease  (28). 
Of course, it should be stressed that the data in the present 
study do not at this stage, establish that  MHC-expressing 
microglia are the only or even a major contributory factor 
in strain resistance. A complex assortment of background genes 
are likely to be involved in susceptibility to EAE (29). This 
is exemplified by the PVG-RTF strain used here, in which 
inducible  corticosterone  levels  are probably the  dominant 
regulatory mechanism (30). Nevertheless,  in other strains such 
as the PVG-RT1  u strain  (same background, different MHC), 
steroid influences are less important  (31).  It remains  to be 
tested whether in strains  like the PVG-RT1 u and in the BN, 
glial ceU-T cell interactions  may contribute to strain resis- 
tance.  To  this  end,  we  are  currently  preparing  modified 
chimeras between the LEW and BN rat strains which will 
allow us to establish unequivocally the influence of the host 
target organ on susceptibility to EAE, and examining whether 
microglia freshly isolated from the BN vs LEW CNS have 
negative rather than positive regulatory influences on T cell 
function in vitro. 
Finally,  it is important  to note the substantial differences 
between the results presented here and some in vitro studies 
on rat and mouse astrocytes (32) and rat brain vascular en- 
dothelial cells (33) where IFN-~/treatment  has been shown 
to induce higher levels of MHC class II expression on ceils 
isolated from EAE-susceptible strains.  Notably, another in 
vitro  study (34)  demonstrated  substantial  IFN-3,-induced 
MHC class II expression on astrocytes from an EAE-resistant 
mouse strain after the astrocytes were cultured for an extended 
period of time. Thus, the contradictory findings may be at- 
tributed to a variety of factors, including the developmental 
stage of the cells (newborn vs adult-derived cells, length of 
culture time),  the fundamental differences between the cell 
types examined, or the fact that the present study addresses 
in vivo rather  than  in vitro phenomena. 
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